$KITE Form 8-K

0
403

Form 8-K for KITE PHARMA, INC.


28-Feb-2017

Results of Operations and Financial Condition, Financial Statements and Exhibit

Item 2.02 Results of Operations and Financial Condition.On February 28, 2017, Kite Pharma, Inc. (“Kite”) provided a corporate update and announced its financial results for the fourth quarter ended December 31, 2016 and its full-year financial results for the year ended December 31, 2016 in the press release attached hereto as Exhibit 99.1 and incorporated herein by reference.

The information in this Item 2.02, including the attached Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing made by Kite under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

Item 9.01 Financial Statements and Exhibits.(d) Exhibits.

The following exhibit is filed as part of this Current Report:

99.1 Press Release of Kite, dated February 28, 2017.

LEAVE A REPLY

Please enter your comment!
Please enter your name here